Scientists unveil drug that thwarts post-operative Crohn’’s disease recurrenceFebruary 2nd, 2009 - 4:34 pm ICT by ANI
Washington, Feb 2 (ANI): A new study has found that a drug called Infliximab can effectively prevent the recurrence of post-operative Crohn’’s disease.
Crohn’’s disease is an inflammatory disease of the digestive system, which may affect any part of the gastrointestinal tract from mouth to anus.
This is the first time that randomised controlled trials have been conducted to evaluate infliximabs efficacy in postoperative Crohn’’s disease prevention.
“Our study provides strong evidence that infliximab is effective at preventing endoscopic, clinical and histological postoperative recurrence of Crohn’’s disease, and provides a rationale for aggressive postoperative chemoprevention with biologic therapy,” said Dr. Miguel Regueiro, of the University of Pittsburgh Medical Center.
“We are encouraged by our findings, which warrant future study of the duration of post-operative infliximab maintenance and appropriate endoscopic follow up,” Regueiro added.
The autoimmune disease commonly recurs after intestinal resection.
During the study, the researchers randomly assigned 24 Crohn’’s disease patients who had undergone intestinal resection to receive intravenous infliximab (5 mg/kg), within four weeks of surgery and continued for one year, or placebo.
They found that, at one year, the rate of endoscopic recurrence was significantly lower in the infliximab group with 9.1 percent compared to the placebo group with 84.6 percent.
Moreover, the histological recurrence rate at one year was significantly lower in the infliximab group with 27.3 percent compared to the placebo group 84.6 percent.
The study appears in the journal Gastroenterology. (ANI)
- Biological agents could prevent Crohn's disease recurrence - Aug 06, 2010
- 2-drug combo effective for Crohn's disease remission - Apr 15, 2010
- Eating strawberries may help prevent esophageal cancer - Apr 07, 2011
- Low-calorie diet tied to bowel disease deaths - Mar 21, 2012
- Broccoli may help fight Crohn's disease - Aug 27, 2010
- Inflammation drug promising in depression - Sep 04, 2012
- Gut probe can spot deadly pancreatic cancer - May 22, 2012
- Fish oil does not help with people with heart rhythm problem: Study - Nov 16, 2010
- Celebrex shows potential in preventing some skin cancers - Dec 01, 2010
- Probiotic bacteria 'could help in Crohn's disease therapy' - Apr 01, 2011
- Not all cases of chronic pancreatitis are alcohol-induced: Study - Mar 12, 2011
- Cranberry juice not effective against urinary tract infections: Study - Dec 09, 2010
- Vitamin D may help fight Crohn's disease - Jan 28, 2010
- MarginProbe System significantly improves breast cancer surgery outcomes - Apr 30, 2011
- Antibiotics may up irritable bowel syndrome risk in kids - Jan 18, 2011
Tags: autoimmune disease, biologic therapy, chemoprevention, crohn s disease, disease of the digestive system, disease patients, disease prevention, disease recurrence, dr miguel, gastrointestinal tract, inflammatory disease, infliximab, journal gastroenterology, pittsburgh medical center, placebo group, post operative, randomised controlled trials, recurrence rate, thwarts, university of pittsburgh medical center